Biotechnology Industry Organization (BIO) Announces Presenting Companies for 12th Annual BIO Investor Forum

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Washington, D.C. (Sept. 11, 2013) – The Biotechnology Industry Organization (BIO) today announced the initial list of presenting companies for the 12th Annual BIO Investor Forum, an international investor forum which explores investment trends and opportunities in life sciences. The event focuses on early and mid-stage private as well as emerging public companies that are poised for growth in 2014. The event will take place October 8-9, 2013 at the Palace Hotel in San Francisco, California.

“We have an incredibly exciting slate of companies lined up for this year’s BIO Investor Forum, with more than 100 companies already scheduled to present,” said Alan Eisenberg, Executive Vice President, Emerging Companies & Business Development at BIO. “Early investor registrations are currently up 33 percent for this year’s BIO Investor Forum, reflecting greatly increased investor interest in the biotech sector.” Companies were chosen through a competitive screening process with input from BIO and the event’s advisory committee. The committee is comprised of members from top-tier firms focused on investing and banking in the life sciences industry in addition to executives from emerging and leading biotech and pharmaceutical companies.

The following companies will present at the 12th Annual BIO Investor Forum:

Private:

Alios BioPharma

Altheus Therapeutics

Ambrx, Inc.

AM-Pharma Holding BV

Aquinox Pharmaceuticals Inc.

Asuragen, Inc.

Auspex Pharmaceuticals, Inc.

Bellicum Pharmaceuticals

BioCrea

Blueprint Medicines

Cerecor, Inc.

ContraFect Corp

CytomX Therapeutics

Dicerna Pharmaceuticals

EGEN, Inc.

Eleison Pharmaceuticals LLC

Elusys Therapeutics

Fate Therapeutics, Inc.

Forma Therapeutics

Generon (Shanghai) Corp. Ltd

Hua Medicine

Igenica

Immune Design Co.

Jennerex Biotherapeutics

KineMed

Labrys Biologics, Inc.

MabVax Therapeutics

MaxCyte, Inc.

Mirna Therapeutics

Opsona Therapeutics

OxThera AB

Polynoma LLC

Probiodrug AG

Protagonist Therapeutics

Proteon Therapeutics

S1 Biopharma

Spring Bank Pharmaceuticals

Syndax Pharmaceuticals

Theraclone Sciences, Inc.

TissueGene

Vaccinex

Versartis

Vivaldi Biosciences, Inc.

Zafgen

Zymeworks

Public:

Ambit Biosciences

Atossa Genetics

Benitec Ltd.

Bio-Path Holdings

Catalyst Pharmaceutical Partners, Inc.

CG Pharmaceuticals, Inc.

Cipher Pharmaceuticals Ltd.

Conatus Pharmaceuticals, Inc.

Critical Outcome Technologies

diaDexus

Galena BioPharma, Inc.

Genesis Biopharma

GensPera, Inc.

Heat Biologics

Horizon Pharma

Innovus Pharma

International Stem Cell Corp.

La Jolla Pharmaceutical Company

Mast Therapeutics

Neostem

Ocera Therapeutics, Inc.

OncoMed Pharmaceuticals

OncoSec

OxiGENE, Inc.

Palatin Technologies

Patrys Ltd.

Resverlogix

RXi Pharmaceuticals

Sernova Corp

Sophiris Bio

Therapeutics MD

ZIOPHARM Oncology Inc.

In addition, the 12th annual BIO Investor Forum will again host Discovery Track presentations, which focus on companies that have raised less than $25M to date in seed or Series A financing rounds. Companies in this track are also first-time presenters and use biotechnology or related technologies for research and development of drug products or diagnostics. The following companies are scheduled to present in the Discovery Track:

Altravax

America Stem Cell

Anthrocell

Applied Integrin Sciences

Armour Therapeutics

BiologicsMD

DiscoveryBioMed, Inc.

DLVR Therapeutics

EicOsis, LLC

FPRT Bio

Gemmus Pharma

GeneCentric Diagnostics

ImmunGene, Inc.

INanoBio

Kala Pharmaceuticals

Leading BioSciences

Maverix Biomics

Max BioPharma

NovelMed Therapeutics

Numab AG

RECARDIO

ScarX Therapeutics

Sensorion Pharmaceuticals

Sialix, Inc.

SironRX Therapeutics

Talon Pharmaceutical Services

TheraVasc

Vascular Pharmaceuticals

viDA Therapeutics

Viking Therapeutics

New presenters are continuously being added. For updates on the list of presenting companies, please visit here. If you are interested in becoming a presenter, please submit an application here.

The BIO Investor Forum is the must-attend event for public and private market investors, research analysts, investment bankers, and industry executives focused on investment and business development opportunities in life sciences. BIO One-on-One Partnering™ will also provide an opportunity to arrange meetings between investors; companies; and industry business development, licensing and therapeutic franchise heads.

BIO is pleased to recognize the leadership provided by the BIO Investor Forum Conference sponsors including our Local Co-Host BayBio and Supporting Banks: Canaccord Genuity, Piper Jaffray and Roth Capital Partners. BIO Double Helix and Helix Sponsors include AbbVie, Amgen, Baxter, Janssen, and Merck. Conference supporters include Blaise Group International, Bristol-Myers Squibb, Chubb, Dectiva, Dentons, Fenwick & West LLP, Knobbe Martens, LaVoie Group, MacDougall Biomedical Communications and SecureDocs.

To learn more about the BIO Investor Forum, including registration and program information, please visit here. Registration is complimentary for credentialed members of the media and qualified investors.

About BIO

BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIO produces BIOtechNOW, an online portal and monthly newsletter chronicling “innovations transforming our world.” Subscribe to BIOtechNOW.

Upcoming BIO Events

BIO Investor Forum

October 8-9, 2013

San Francisco, CA

BIO IPCC Conference

November 6-8, 2013

Washington, DC

BIO Convention in China

November 11-13, 2013

Beijing, China

Pacific Rim Summit on Industrial Biotechnology & Bioenergy

December 8-11, 2013

San Diego, CA

BIO CEO & Investor Conference February 10 – 11, 2014

New York, NY

BIO Asia International Conference

April 8-9, 2014

Tokyo, Japan

BIO International Convention

June 23-26, 2014

San Diego, CA

Help employers find you! Check out all the jobs and post your resume.

Back to news